B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression
Jonathan M. Irish(Vanderbilt University), Ronald Levy(Hôpital Necker-Enfants Malades), Jeff P. Sharman(Willamette Valley Cancer Institute and Research Center), Roch Houot(Inserm), Garry P. Nolan(Stanford University), June H. Myklebust(Oslo University Hospital), Debra K. Czerwinski(Stanford University), Ash A. Alizadeh(California Institute for Regenerative Medicine)
Cited by 168
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k